NYSE$BHC
Bausch Health Companies Inc · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
Bausch Health announced an agreement with Carl C. Icahn, appointing two new directors to the board and securing Icahn's support for all Bausch Health nominees at the 2021 Annual Meeting.
Bausch Health reached an agreement with the Icahn Group, appointing Brett Icahn and Steven Miller as new independent directors to the Board, effective mid-March 2021. The Icahn Group, owning approximately 7.83% of the Company’s outstanding common stock, agreed to vote in favor of the Board’s nominees at the 2021 Annual Meeting.
- Two new independent directors, Brett Icahn and Steven Miller, will be appointed to Bausch Health's Board in mid-March 2021.
- The Icahn Group, holding approximately 7.83% of Bausch Health's common stock, will support all Bausch Health nominees at the 2021 Annual Meeting.
- The new directors will serve on the Finance and Transactions Committee and the committee assisting with evaluating strategic alternatives, including the potential spin-off of the eye health business.
- The agreement aims to unlock unrecognized value in Bausch Health and build on progress in capitalizing on areas of unmet medical need and gaining market share.
Headline financials
Revenue & EPS history
Bausch Health · Revenue · Quarterly
$2.21B
Revenue by segment
Bausch Health · $1.88B total across 3 segments · Q3 2023
- Bausch + Lomb/International$1.01B+6.9%53.6%
- Salix$614M+12.9%32.7%
- Diversified Products$259M+8.8%13.8%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2020
+0.2%
Avg return
Earnings day
-0.6%
Avg return
5 days after
-1.9%
Avg return
30 days after
51%
35 / 68 earnings
Positive
+30.6%
Q1 2017
Best reaction
-21.5%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +10.9% | +0.9% | -4.1% | |
| Q4 2025 | -4.5% | -2.7% | -19.1% | |
| Q3 2025 | +12.4% | +14.2% | +7.6% | |
| Q1 2025 | +0.0% | -10.6% | -14.5% | |
| Q4 2024 | +10.3% | +15.8% | +10.0% | |
| Q3 2024 | +12.7% | +13.5% | +2.6% | |
| Q2 2024 | -6.6% | -10.6% | -1.7% | |
| Q1 2024 | -10.6% | -15.3% | -25.0% | |
| Q4 2023 | +5.9% | +5.9% | +10.3% | |
| Q3 2023 | +6.9% | +2.4% | +4.0% | |
| Q2 2023 | -2.9% | -4.6% | -9.3% | |
| Q1 2023 | -21.2% | -20.8% | +11.2% | |
| Q4 2022 | +10.8% | +7.8% | -16.3% | |
| Q3 2022 | +7.5% | +8.4% | +21.4% | |
| Q2 2022 | -3.3% | +2.9% | +14.7% | |
| Q1 2022 | -21.5% | -16.0% | -35.0% | |
| Q4 2021 | -1.9% | +1.9% | -3.3% | |
| Q3 2021 | -4.5% | -1.9% | -17.8% | |
| Q2 2021 | -15.5% | -10.1% | -0.7% | |
| Q1 2021 | -10.8% | -10.6% | +0.9% | |
| Q4 2020 | -0.9% | +0.6% | -1.8% | |
| Q3 2020 | -3.1% | -4.0% | +11.0% | |
| Q2 2020 | -7.2% | -9.2% | -16.3% | |
| Q1 2020 | -1.8% | +0.2% | +12.4% | |
| Q4 2019 | -5.8% | -7.3% | -51.3% | |
| Q3 2019 | +0.8% | +1.1% | +10.6% | |
| Q2 2019 | -4.0% | -3.0% | -6.9% | |
| Q1 2019 | +8.7% | +8.0% | -9.0% | |
| Q4 2018 | -6.7% | -7.3% | -2.0% | |
| Q3 2018 | +6.1% | +6.4% | -5.2% | |
| Q2 2018 | +5.4% | -2.9% | -7.3% | |
| Q1 2018 | +11.5% | +14.8% | +37.4% | |
| Q4 2017 | -17.5% | -16.8% | -13.9% | |
| Q3 2017 | +23.6% | +27.7% | +46.4% | |
| Q2 2017 | -8.5% | -9.6% | -12.9% | |
| Q1 2017 | +30.6% | +40.0% | +36.6% | |
| Q4 2016 | -18.7% | -21.8% | -33.7% | |
| Q3 2016 | -15.9% | -5.9% | -19.3% | |
| Q2 2016 | +21.7% | +11.0% | +33.5% | |
| Q1 2016 | -17.1% | -16.3% | -18.6% | |
| Q4 2015 | -7.4% | — | — | |
| Q3 2015 | -17.4% | — | — | |
| Q2 2015 | +5.4% | — | — | |
| Q1 2015 | +5.6% | — | — | |
| Q4 2014 | +14.7% | — | — | |
| Q3 2014 | +8.5% | — | — | |
| Q2 2014 | -6.1% | — | — | |
| Q1 2014 | -1.6% | — | — | |
| Q4 2013 | -1.0% | — | — | |
| Q3 2013 | +2.0% | — | — | |
| Q2 2013 | +6.2% | — | — | |
| Q1 2013 | +1.8% | — | — | |
| Q4 2012 | +1.3% | — | — | |
| Q3 2012 | -2.6% | — | — | |
| Q2 2012 | +2.2% | — | — | |
| Q1 2012 | +2.1% | — | — | |
| Q4 2008 | +6.3% | — | — | |
| Q4 2010 | +6.3% | — | — | |
| Q4 2011 | +6.3% | — | — | |
| Q3 2011 | -2.9% | — | — | |
| Q2 2011 | +3.9% | — | — | |
| Q1 2010 | +0.0% | — | — | |
| Q1 2011 | +6.3% | — | — | |
| Q3 2010 | -5.4% | — | — | |
| Q3 2009 | -5.4% | — | — | |
| Q2 2009 | +2.0% | — | — | |
| Q2 2010 | +2.0% | — | — | |
| Q4 2009 | +2.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro